Navigation Links
VCA fellowship funding to extend ovarian cancer research

Dr Clare Scott from the Walter and Eliza Hall Institute in Melbourne, Australia, has been awarded a Victorian Cancer Agency (VCA) Clinical Fellowship to further research into an aggressive and highly lethal form of ovarian cancer.

Epithelial ovarian cancer, which is found in the cell lining (epithelium) of the ovary, accounts for 90 per cent of ovarian tumours. However, epithelial ovarian cancer is still poorly understood, and recent research has revealed that it may start in cells outside of the ovary.

Dr Scott is a laboratory head in the institute's Stem Cells and Cancer and Molecular Genetics of Cancer divisions and a medical oncologist at The Royal Melbourne Hospital. She said the VCA fellowship, worth $400,000 over two years, would help her to search for the origins of ovarian cancer.

"In addition to working out where ovarian cancer starts, we need more precise ways of studying human ovarian cancers in the laboratory and, with the VCA funding, we will work on improving those laboratory models," Dr Scott said.

"Because ovarian cancer becomes resistant to current therapies so often, it is essential that we discover new treatments. Being able to accurately study human ovarian cancers in animal models provides great advantages in this regard."

Dr Scott said the VCA funding would help to further fundamental research in the area, including the development of a more useful pre-clinical model for ovarian cancer than is currently available for testing new drugs.

Each year, more than 1200 Australian women are diagnosed with ovarian cancer, and around 800 will die from the disease. Ovarian cancer is the sixth major cause of cancer deaths in Australian women. Despite efforts to develop better screening tools, 80 per cent of epithelial ovarian cancers are diagnosed after they have spread beyond the ovary and 70 per cent are generally incurable.

Dr Scott is also the principal investigator in a program called, which receives funding from the Victorian Cancer Agency. is a web portal dedicated to coordinating patient information, research studies and clinical trials for rare cancers. Dr Scott will use this web portal to study rare ovarian cancers.

"The website provides a new way of linking patients into the system of research and clinical trials," Dr Scott said. "This increases the number of patients available for specialised research, with the ultimate goal of gathering enough entries over time to make clinical trials for different types of rare tumours a possibility."


Contact: Penny Fannin
Walter and Eliza Hall Institute

Related medicine news :

1. Fellowship allows diverse reporters to cultivate public awareness of aging issues
2. AWARD Fellowship highlights critical role of African women in agricultural research
3. Kennedy Krieger Institutes Dr. Paul Lipkin selected for national health policy fellowship
4. Outstanding high school students receive AGA Foundation 2010 Student Research Fellowship Awards
5. University of Toronto scholars receive prestigious New Directions Fellowships
6. Fellowship winners make cancer their focus
7. AADR awards the 2010 AADR William B. Clark Fellowship to Isabel Gay
8. UCI stem cell researchers to receive $9.35 million in state funding
9. Hepatitis E research receives funding
10. MJFF announces over $10 million in funding for clinical and pre-clinical PD research
11. UCI gets major funding to study ways of preventing drug-resistant staph infections
Post Your Comments:
Related Image:
VCA fellowship funding to extend ovarian cancer research
(Date:11/30/2015)... ... November 30, 2015 , ... ... announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming ... value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, and Intel ...
(Date:11/30/2015)... EMIGSVILLE, PA (PRWEB) , ... November 30, 2015 ... ... (CCMS) software provider, has verified that their Vasont Universal Integrator (VUI) extension unites ... handle creating, editing, and managing content as a continuous process with the latest ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... is one of a select few plastic surgeons in the New York City ... , SculpSure™ is the world’s first heat-induced laser treatment for fat loss in ...
(Date:11/30/2015)... ... November 30, 2015 , ... TransPack Volume 6 features 30 customizable transitions created ... web-styled transitions to wipes with blur & drop shadow options. Utilize the controls ... from one clip to the next with TransPack's easily customizable styles. , ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... Inc. are pleased to announce their strategic partnership at the Radiological Society ... Transcription Service, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Calif. , Nov. 30, 2015 /PRNewswire/ ... the norm in U.S. medical imaging is ... increasingly popular accountable care payer-provider contracts are ... and, in their wake, alter provider-vendor relationships. ... payments will push forward new purchasing frameworks ...
(Date:11/30/2015)... JERUSALEM , Nov. 30, 2015 Oramed ... company focused on the development of oral drug delivery ... investment agreements valued at up to $50,000,000 with Hefei Tianhui Incubator of ... Oramed,s oral insulin capsule, ORMD-0801, in China ... Macau . The agreements were signed ...
(Date:11/30/2015)... N.H. , Nov. 30, 2015 ... that it will feature its latest solutions for ... early identification of cancer at the Radiological Society ... Chicago from November 29 ... recent product advances including iReveal®, an automated breast ...
Breaking Medicine Technology: